MediPoint: Partial Knee Replacement – Middle East and Africa Analysis and Market Forecasts
- Pages: 38
- Published: June 2017
- Report Code: GDME1409CFR
Partial knee replacement (PKR), or unicondylar knee arthroplasty (UKA), is an alternative to total knee arthroplasty (TKA) used to treat patients whose osteoarthritic condition is isolated to the medial or lateral tibio-femoral compartments. PKR is a less invasive procedure than TKA that replaces only the damaged part of the joint with a prosthesis, resulting in less blood loss and the preservation of healthy ligaments, cartilage, and bone in the knee. The decision to undergo a PKR instead of TKR is based on the disease stage, patient expectations, published results, and surgeon expertise. Studies have shown that compared to TKR, PKR performed with accurate technique and proper patient selection offers advantages that include a high rate of return to sport, fewer complications, and cost savings. PKR is contraindicated for inflammatory arthritis, multicompartment disease, severe subluxation, non-articular deformity, and anterior cruciate ligament (ACL) deficiency. Yet, with improvements in surgical techniques and technology, the indications and effectiveness of PKR procedures has increased. GlobalData believes that active adults who want to lead a pain-free active lifestyle as they age will drive the procedure volume of PKR in the forecast period.
This report focuses on the market outlook for PKR devices in the Middle East and Africa (Egypt, Israel, Saudi Arabia, South Africa, and United Arab Emirates). The analysis identifies the key unmet needs in the PKR market, discusses the major drivers and barriers of adoption, and provides an in-depth understanding of physicians’ perceptions and the future outlook for this market by segment and geography.
Key Questions Answered in This Report:
What is the current and future PKR market outlook in the developed and emerging markets? What trends are affecting the Middle East and African market?
Which are the key, high growth markets that PKR manufacturers should expand into?
What are the unmet needs with the current generation of PKR devices? How will emerging technologies fulfill these unmet needs?
What are the challenges and complications that have hindered widespread adoption?
With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the PKR market?
Overview of recent key industry events and analysis of their market impact.
Annualized total market revenue, procedure trends, and market outlooks by segment and by region through 2023.
Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies in the market.
Analysis of the current and future market competition in the global PKR market. Insightful review of industry drivers, barriers, and challenges.
Reasons to buy
The report will enable you to:
Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.
Develop business strategies by understanding the trends shaping and driving the video laparoscopes market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the video laparoscopes market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Track device sales in country-specific video laparoscopes market from 2014-2023.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Smith & Nephew
Table of Contents
Table of Contents
1 About the Authors
1.1.1 Tobe Madu, MSc, Analyst, Medical Devices
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Executive Summary
3.1 Key Metrics
3.2 Market Dynamics
3.3 Key Players
3.4 Future Outlook
3.5 What Do Physicians Think?
4.2 Related Reports
4.3 Upcoming Related Reports
5 Market Outlook
5.1 Procedure Trends
5.2 Pricing Trends
5.3 Revenue Trends
5.4 Company Share Analysis
6 Market Insights
6.1 Middle East and Africa
6.1.2 South Africa
6.1.3 Egypt, Saudi Arabia, and UAE
7 Competitive Assessment
7.1.1 Robotic Technologies
7.1.2 Generic Implants to Address Cost Concerns
7.1.3 Advanced Materials
7.1.4 Emerging Countries
7.2 DePuy Synthes
7.2.1 Portfolio Assessment
7.2.2 Deal Analysis
7.2.3 Competitive Positioning
7.3.1 Portfolio Assessment
7.3.2 Deal Analysis
7.3.3 Competitive Positioning
7.4 Smith & Nephew
7.4.1 Portfolio Assessment
7.4.2 Deal Analysis
7.4.3 Competitive Positioning
7.5 Zimmer Biomet
7.5.1 Portfolio Assessment
7.5.2 Deal Analysis
7.5.3 Competitive Positioning
7.6 Other Players
8.4.3 Secondary Research
8.4.4 Forecasting Methodology
8.4.5 Primary Research Summary
8.5 About MediPoint
8.6 About GlobalData
8.7 Contact Us
List of Tables
Table 1: PKR Market, Key Metrics, 2016–2023
Table 2: Middle East and Africa PKR Procedure Volume Forecast, 2014–2023
Table 3: Middle East and Africa PKR Implant Average Selling Price ($) Forecast, 2014–2023
Table 4: Middle East and Africa PKR Market Revenue Forecast ($M), 2014–2023
Table 5: Middle East and Africa PKR Company Share Analysis, 20161, 2
Table 6: DePuy Synthes – Key Marketed Products Assessment
Table 7: DePuy Synthes – Key Clinical Trials
Table 8: Stryker – Key Marketed Products Assessment
Table 9: Stryker – Key Clinical Trials
Table 10: Smith & Nephew – Key Marketed Products Assessment
Table 11: Zimmer Biomet – Key Marketed Products Assessment
Table 12: Summary of Other Players in the PKR Market, 2016
List of Figures
Figure 1: Middle East and Africa PKR Market Share Comparison by Country, 2016 and 2023